- Carotid artery angioplasty and stenting
- Vertebroplasty
- Stroke therapy
- Pre-operative tumour embolization
Interventional Neurology Devices Market size valued USD 2.5 billion in 2022 and is poised to grow at a CAGR of 9.2% from 2023-2029. Interventional neurology is a speciality which utilizes the minimally invasive procedures with image-guided techniques for the diagnosis and treatment of various chronic neurological diseases related to veins & arteries of neck, brain, and spine. The most commonly treated diseases with interventional neurology include head and neck tumours, ischemic strokes, meningiomas, spinal vascular malformations, cerebral aneurysm, and intracranial atherosclerosis among others. Different types of materials such as cobalt, platinum, and nitinol are used in neurovascular devices for ischemic stroke prevention and aneurysm. Increase in the global aging population, technological advancements in the interventional neurology devices, a rise in prevalence of ischemic stroke and hemorrhagic conditions, and growing demand for minimally invasive procedures are anticipated to fuel the interventional neurology devices market. Furthermore, advantages of an interventional procedure such as the minimal possibility of infection and surgical trauma, favourable reimbursement policies, and rise in product development and commercialization are expected to bolster the interventional neurology devices market over the forecast period. However, stringent regulatory guidelines for the product approvals, a high cost of the treatment, and lack of skilled professionals might impede the growth of  the market.
Interventional Neurology Devices Market Key Developments:
- In June 2017, DePuy Synthes acquired Sentio, LLC to enable the innovation in minimally invasive surgery of spine In October 2016, St. Jude Medical, Inc. received FDA approval for Amplatzer PFO used in the treatment of recurrent ischemic stroke and launched in U.S. market
Global Interventional Neurology Devices Market Summary
Study Period
2023-29
Base Year
2022
CAGR
9.2%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Interventional Neurology Devices Market Dynamics
Interventional Neurology Devices Market is growing at a significant CAGR owing to increase in the demand for minimally invasive neurological surgical procedures. A rise in the prevalence of neurological disorders (according to World Health Organization, more than 6.8 Mn people are dying from neurological disorders) expected to drive the revenue growth of interventional neurology devices market. Moreover, a majority of the market players are focusing on the development of novel devices with minimally invasive techniques. Acquisitions and mergers, collaborations, product approvals, and launchings are strategies followed by the companies for dominating the interventional neurology devices market. For instance, in June 2016, Terumo Corporation acquired Sequent Medical, Inc. for the development of a novel medical device for the aneurysm embolization. Moreover, in January 2012, Covidien received FDA approval for the Solitaire revascularization device interventional management of stroke trial.
North America Got Significant Share
Interventional Neurology Devices Market Regional Analysis
The geographically Interventional Neurology Devices Market is segmented into North America, Latin America, Middle East and Africa, Asia Pacific, and Europe. North America holds a significant share in interventional neurological devices market owing to increase in the prevalence of cerebrovascular disorders majorly in U.S., which is approximately 1,683 per 100,000 population. Moreover, a rise in technological advancements, approval of novel products by FDA, an increase in healthcare expenditure are driving the interventional neurology devices market. Europe has a lucrative growth due to increase in the prevalence of neurological disorders majorly in Russia, Latvia, Bulgaria, and Lithuania. In addition, technological advances in interventional neurological devices, well-developed healthcare infrastructure, and product approvals from EMEA are anticipated to bolster the interventional neurology devices market in the region. However, Asia Pacific is an emerging region for interventional neurology devices market due to rise in geriatric population majorly in India, China, and Japan, increase in the medical tourism, and growing demand for minimally invasive procedures in the region.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Global Interventional Neurology Devices Market Segmentation
By Product Type
By Indication
- Cerebral aneurysm
- Ischemic strokes
- Arteriovenous malformations and Fistulas
- Others
By End User
- Hospitals
- Neurology Clinics
- Ambulatory surgical centres
By Technology Type
- Carotid artery angioplasty and stenting,
- Vertebroplasty,
- Stroke therapy,
- Pre-operative tumour embolization
Frequently Asked Questions
The key segments covered in the interventional neurology devices market are: by product type, technology type, indication, end-users and geography
The interventional neurology devices market key players are Medtronic plc) (Ireland), Stryker Corporation (U.S.), Depuy Synthes (Johnson and Johnson Services Inc.) (U.S.), Abbott Laboratories (U.S.), Terumo Corporation (Japan), Bayer AG (Germany), Boston Scientific Corporation (U.S.), Penumbra, Inc. (U.S.)
North America is the fastest-growing region for interventional neurology devices market
| 1. Executive Summary |
| 2. Global Interventional Neurology Devices Market Introduction |
| 2.1.Global Interventional Neurology Devices Market - Taxonomy |
| 2.2.Global Interventional Neurology Devices Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Indication |
| 2.2.3.End User |
| 2.2.4.Technology Type |
| 2.2.5.Region |
| 3. Global Interventional Neurology Devices Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Interventional Neurology Devices Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Interventional Neurology Devices Market By Product Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Carotid artery angioplasty and stenting |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Vertebroplasty |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Stroke therapy |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Pre-operative tumour embolization |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global Interventional Neurology Devices Market By Indication, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Cerebral aneurysm |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Ischemic strokes |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Arteriovenous malformations and Fistulas |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Global Interventional Neurology Devices Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Neurology Clinics |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Ambulatory surgical centres |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Global Interventional Neurology Devices Market By Technology Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. Carotid artery angioplasty and stenting, |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Vertebroplasty, |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Stroke therapy, |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Pre-operative tumour embolization |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9. Global Interventional Neurology Devices Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10. North America Interventional Neurology Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Carotid artery angioplasty and stenting |
| 10.1.2.Vertebroplasty |
| 10.1.3.Stroke therapy |
| 10.1.4.Pre-operative tumour embolization |
| 10.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Cerebral aneurysm |
| 10.2.2.Ischemic strokes |
| 10.2.3.Arteriovenous malformations and Fistulas |
| 10.2.4.Others |
| 10.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Neurology Clinics |
| 10.3.3.Ambulatory surgical centres |
| 10.4. Technology Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Carotid artery angioplasty and stenting, |
| 10.4.2.Vertebroplasty, |
| 10.4.3.Stroke therapy, |
| 10.4.4.Pre-operative tumour embolization |
| 10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11. Europe Interventional Neurology Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Carotid artery angioplasty and stenting |
| 11.1.2.Vertebroplasty |
| 11.1.3.Stroke therapy |
| 11.1.4.Pre-operative tumour embolization |
| 11.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Cerebral aneurysm |
| 11.2.2.Ischemic strokes |
| 11.2.3.Arteriovenous malformations and Fistulas |
| 11.2.4.Others |
| 11.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Neurology Clinics |
| 11.3.3.Ambulatory surgical centres |
| 11.4. Technology Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Carotid artery angioplasty and stenting, |
| 11.4.2.Vertebroplasty, |
| 11.4.3.Stroke therapy, |
| 11.4.4.Pre-operative tumour embolization |
| 11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 11.5.7. |
| 12. Asia Pacific (APAC) Interventional Neurology Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Carotid artery angioplasty and stenting |
| 12.1.2.Vertebroplasty |
| 12.1.3.Stroke therapy |
| 12.1.4.Pre-operative tumour embolization |
| 12.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Cerebral aneurysm |
| 12.2.2.Ischemic strokes |
| 12.2.3.Arteriovenous malformations and Fistulas |
| 12.2.4.Others |
| 12.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Neurology Clinics |
| 12.3.3.Ambulatory surgical centres |
| 12.4. Technology Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Carotid artery angioplasty and stenting, |
| 12.4.2.Vertebroplasty, |
| 12.4.3.Stroke therapy, |
| 12.4.4.Pre-operative tumour embolization |
| 12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13. Middle East and Africa (MEA) Interventional Neurology Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Carotid artery angioplasty and stenting |
| 13.1.2.Vertebroplasty |
| 13.1.3.Stroke therapy |
| 13.1.4.Pre-operative tumour embolization |
| 13.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Cerebral aneurysm |
| 13.2.2.Ischemic strokes |
| 13.2.3.Arteriovenous malformations and Fistulas |
| 13.2.4.Others |
| 13.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Neurology Clinics |
| 13.3.3.Ambulatory surgical centres |
| 13.4. Technology Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Carotid artery angioplasty and stenting, |
| 13.4.2.Vertebroplasty, |
| 13.4.3.Stroke therapy, |
| 13.4.4.Pre-operative tumour embolization |
| 13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14. Latin America Interventional Neurology Devices Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Carotid artery angioplasty and stenting |
| 14.1.2.Vertebroplasty |
| 14.1.3.Stroke therapy |
| 14.1.4.Pre-operative tumour embolization |
| 14.2. Indication Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Cerebral aneurysm |
| 14.2.2.Ischemic strokes |
| 14.2.3.Arteriovenous malformations and Fistulas |
| 14.2.4.Others |
| 14.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Hospitals |
| 14.3.2.Neurology Clinics |
| 14.3.3.Ambulatory surgical centres |
| 14.4. Technology Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Carotid artery angioplasty and stenting, |
| 14.4.2.Vertebroplasty, |
| 14.4.3.Stroke therapy, |
| 14.4.4.Pre-operative tumour embolization |
| 14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Medtronic plc) (Ireland) |
| 15.2.2.Stryker Corporation (U.S.) |
| 15.2.3.Depuy Synthes (Johnson and Johnson Services Inc.) (U.S.) |
| 15.2.4.Abbott Laboratories (U.S.) |
| 15.2.5.Terumo Corporation (Japan) |
| 15.2.6.Bayer AG (Germany) |
| 15.2.7.Boston Scientific Corporation (U.S.) |
| 15.2.8.Penumbra, Inc. (U.S.) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Medtronic plc) (Ireland)
- Stryker Corporation (U.S.)
- Depuy Synthes (Johnson and Johnson Services Inc.) (U.S.)
- Abbott Laboratories (U.S.)
- Terumo Corporation (Japan)
- Bayer AG (Germany)
- Boston Scientific Corporation (U.S.)
- Penumbra, Inc. (U.S.)